Clovis Oncology Stock News

Clovis (CLVS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Clovis Oncology's (CLVS) sole marketed drug Rubraca has been approved for multiple cancer indications. Yet, the drug's sales remain tepid on account of competition from PARP inhibitors.

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.

Acadia Pharmaceuticals and Clovis Oncology may be turnaround stories in the making.

Why top investors are watching these penny stocks right now The post 3 Penny Stocks That Top Investors Are Watching in October appeared first on Penny Stocks to Buy, Picks, News and Information | Penn

Biotech penny stocks are heating up right now, here's three to watch The post Are Biotech Penny Stocks Worth Buying? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and Informatio

Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.

News of regulatory approval or progress would really help to move the needle for these seven biotech penny stocks. The post 7 Penny Stocks Waiting on The FDA for Rocket Fuel appeared first on Investor

Clovis Oncology Inc. ( CLVS , Financial) and Denali Therapeutics Inc. ( DNLI , Financial) are among the most likely biotechs to be acquired, according to industry publications. Denali, by far, would b

Short squeeze penny stocks are some of the most-searched for in the stock market today. The post Most Shorted Penny Stocks To Buy Today?

Shares of the biotech that focuses on oncology drugs climbed more than 12% during the week.

The SPRT stock breakout has shed light on other short-squeeze penny stocks The post 4 Short Squeeze Penny Stocks To Watch After SPRT Stock's 1,309% Run appeared first on Penny Stocks to Buy, Picks, Ne

Short-squeeze stocks continue to be popular among retail traders as they look for targets to pump higher and we've got a list to watch. The post Short-Squeeze Stocks: Top 10 Stocks With High Short Int

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology Announces Availability of and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in Switzerland

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (NASDAQ:CLVS) announced today that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (“SEC”) to renew its